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Abstract
Objectives: To identify genomic regions associated with fasting plasma lipid profiles, insulin,
glucose, and glycosylated hemoglobin in a Yup’ik study population, and to evaluate whether the
observed associations between genetic factors and metabolic traits were modified by dietary intake
of marine derived omega-3 polyunsaturated acids (n-3 PUFA).
Methods: A genome-wide linkage scan was conducted among 982 participants of the Center for
Alaska Native Health Research study. n-3 PUFA intake was estimated using the nitrogen stable
isotope ratio (δ15N) of erythrocytes. All genotyped SNPs located within genomic regions with
LOD scores > 2 were subsequently tested for individual SNP associations with metabolic traits
using linear models that account for familial correlation as well as age, sex, community group and
n-3 PUFA intake. Separate linear models were fit to evaluate interactions between the genotype of
interest and n-3 PUFA intake.
Results: We identified several chromosomal regions linked to serum apolipoprotein A2, high
density lipoprotein-, low density lipoprotein-, and total cholesterol, insulin, and glycosylated
hemoglobin. Genetic variants found to be associated with total cholesterol mapped to a region
containing previously validated lipid loci on chromosome 19, and additional novel peaks of
biological interest were identified at 11q12.2-11q13.2. We did not observe any significant
interactions between n-3 PUFA intake, genotypes, and metabolic traits.
Conclusions: We have completed a whole genome linkage scan for metabolic traits in Native
Alaskans, confirming previously identified loci, and offering preliminary evidence of novel loci
implicated in chronic disease pathogenesis in this population.
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The prevalence of type 2 diabetes (T2D) in Alaska Native communities has historically been
lower than the general US population, although the specific genetic and environmental
factors that underlie these statistics remain poorly characterized. Accumulating evidence
suggests that elements of the traditional diet such as omega-3 polyunsaturated fatty acids
(n-3 PUFA) and low carbohydrate content (Naylor et al., 2003) may contribute to the low
T2D prevalence in these communities. More recently, Alaska Native people have
experienced a more dramatic rise in T2D burden than other Native groups, with the age-
adjusted prevalence increasing from 17.3/1,000 in 1985 to 47.6/1,000 (Narayanan et al.,
2010). This increase may be attributed to increased awareness, improved access to
healthcare, decreased overall mortality rates, a change in diagnostic criteria in 1997, as well
as nutritional and lifestyle transitions (Naylor et al., 2003). Moreover, the effects of the
changing diet on chronic metabolic disease risk may be mediated by genetic factors that are
unique to isolated populations (Lemas et al., 2013).
Current understanding of the genetics of metabolic traits among circumpolar populations is
limited in comparison to other ethnic groups, highlighting the need for comprehensive scans
to identify the major susceptibility loci. Two recent candidate gene studies, conducted
among the Canadian Inuit (Rudkowska et al., 2013) and Yup’ik people living in Southwest
Alaska (Lemas et al., 2012) suggested that consumption of marine-derived n-3 PUFA may
influence lipid traits through interactions with common genetic variants implicated in
metabolic pathways. However, few studies have comprehensively examined the role of
genes or gene-diet interactions in the etiology of metabolic traits in communities with a
historically low prevalence of T2D, despite ample evidence of their etiologic relevance in
other populations (Ntzani and Kawoura, 2012; Franks et al., 2007; Cole et al., 2005).
Rudkowska et al. showed that the minor allele frequency distribution of several metabolism-
related genetic markers differs markedly between the Inuit and Caucasians, and other studies
of complex traits (Hegele et al., 1997; Hegele et al., 1999) also suggest differences in
susceptibility genes. To further elucidate these differences, the purpose of this study was to
examine the genetic architecture of metabolic traits in a Yup’ik population using whole-
genome linkage analysis, followed by targeted association testing for variants genotyped
within the observed peaks. Additionally, this study investigated potential interactions of
these loci with habitual intake of marine-derived n-3 PUFA.
MATERIALS AND METHODS
Participants
The Center for Alaska Native Health Research (CANHR) studies genetic, behavioral, and
dietary risk factors underlying obesity and their relationship to diabetes and cardiovascular
disease among the Yup’ik people (Mohatt et al., 2007). Recruitment of Yup’ik participants
was initiated in 2003 and continues in 11 Southwest Alaska communities. All residents are
invited to participate, with the study sample age distribution reflecting that of all eligible
participants as summarized by the 2000 U.S. census. The analyses in this report were
performed on 1136 non-pregnant Yup’ik people that were ≥14 years old at the time of
enrollment.
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Ethics
Participants provided written informed consent using protocols approved by the University
of Alaska Institutional Review Board, the National and Alaska Area Indian Health Service
Institutional Review Boards, and the Yukon Kuskokwim Human Studies Committee.
Measurements of metabolic traits
A radioimmunoassay kit was used to assay fasting insulin (FI) with an I125-iodinated insulin
tracer, anti-human insulin specific antibody, and human insulin standards (Linco Research,
St Charles, MO, USA), for which the intra- and inter-assay variations were respectively
5.8% and 10.2%. A Cholestech LDX analyzer was used to measure fasting glucose (FG),
and glycosylated hemoglobin (HbA1c) was quantified with a DCA 2000+ analyzer (Bayer
AG, Leverkusen, Germany). Lipid profiles, specifically low-density lipoprotein (LDL)
cholesterol, high-density lipoprotein (HDL) cholesterol, very low-density lipoprotein
(VLDL) cholesterol, total cholesterol, triglycerides (TG), and apolipoproteins A1 (ApoA1)
and A2 (ApoA2) were measured as described in previous publications from our group
(Lemas et al., 2012; Boyer et al., 2007).
Dietary n-3 PUFA intake measurements
The nitrogen stable isotope ratio (δ15N) of red blood cells (RBC) was used to assess n-3
PUFA intake as previously described (O’Brien et al., 2009). RBC aliquots were autoclaved
for 20 minutes at 121° C to destroy blood-borne pathogens, and samples were weighed into
3.5 × 3.75 mm tin capsules and freeze dried to a final mass of 0.2 - 0.4 mg. Samples were
analyzed at the Alaska Stable Isotope Facility by continuous-flow isotope ratio mass
spectrometry, using a Costech ECS4010 Elemental Analyzer (Costech Analytical
Technologies, Valencia, CA, USA) interfaced to a Finnigan Delta Plus XP isotope ratio
mass spectrometer via the Conflo III interface (Thermo-Finnigan Inc., Bremen, Germany).
The conventional method of expressing nitrogen isotope ratios at natural abundance is in
“permil” (%0) abundance of 15N relative to atmospheric nitrogen (15N/14Natm = 0.0036765),
as follows:
δ15N = [(15N/14Nsample – 15N/14Natm)/( 15N/14Natm)] · 1000%0. Laboratory reference
materials (peptone, δ15N = 7.00) were concurrently prepared and run to assess analytical
accuracy and precision; these were analyzed after every eighth sample and estimated δ15N at
7.0 ± 0.2%0 (mean ± SD). The range of isotopic variation in the data (9%0) was very large
relative to analytical precision (0.2%0). To avoid undue influence of extreme values and
allow for a non-linear relationship suggested by prior evidence, this variable was modeled as
a categorical variable, defined by the quartiles of the δ15N measurements. We identified the
quartiles of values of δ15N, and assigned values to three dichotomous variables as follows.
Individuals with values below the first quartile were assigned (0,0,0) to the three variables.
Those with values at least equal to the first quartile but below the second were given the
values (1,0,0). Those with values at least equal to the second quartile but below the third
were given the values (1,1,0). Finally, those with values at least equal to the third quartile
were given the values (1,1,1).
Genotyping
Participants were genotyped for 6090 single nucleotide polymorphisms (SNPs) from the
Illumina’s Linkage-IV panel (Illumina, San Diego, CA, USA) at the Center for Inherited
Disease Research (CIDR). The Illumina Linkage-12 panel spans the entire genome with an
average genetic distance of 0.58 cM and 441 kb physical map spacing.
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Pedigree analysis
Pedigree data was extracted from the Progeny database (Progeny Software LLC, South
Bend, IN, USA), and merged as appropriate into larger pedigrees using the program
Pedmerge Pedmerge allows for accurate and efficient merger of separately ascertained
pedigrees that belong to the same extended family (Plaetke and Balbi, 2010). The 1136
individuals included in this study were members of 63 independent pedigrees. Among these,
21 pedigrees contained at least two individuals and 42 individuals were singletons; both
categories were subsequently excluded from the linkage analyses. The majority of the
genotyped participants (n=1037) were members of the single largest pedigree, which was
too large to analyze with standard frequentist methods. For this reason, that pedigree was cut
using Pedstr into 113 smaller, independent sub-pedigrees each containing between 2 and 22
genotyped participants. Pedstr is an automatic algorithm that splits large pedigrees into
fragments of specified size, which can subsequently be used in multi-point linkage analysis
(Kirichenko et al., 2009). Of the total 938 genotyped participants in these cut pedigrees, 52
were repeated once or twice (e.g. as a founder in one pedigree and a child in another) to
maintain close relationships; 883 of the original genotyped participants were retained. The
remaining 154 genotyped individuals were not closely related to any of the retained
participants. A summary of the relative pairs included in the analysis is given in Table 1.
Quality control of phenotypic and genotypic data
Simple linear models were fitted to outcome variables using all available non-genetic
covariates, and descriptive statistics of the residuals were examined using R software
(v2.10.1, R Development Core, 2009). If necessary, traits were transformed using either
logarithmic (for HDL and TG) or Box-Cox approaches (Box and Cox, 1964) (for ApoA1,
ApoA2, FG, FI, HbA1C) to reduce the residual kurtosis of the traits and avoid artificially
inflated evidence for linkage (Blangero et al., 2001). Estimates of heritability and residual
kurtosis for raw or appropriately transformed traits are given in Table 2. All traits exhibited
statistically significant heritability estimates. For the traits that still had residual kurtosis
above 0.8 (ApoA2, FG, HbA1c, FI, and untransformed LDL), subsequent linkage analyses
used the t-distribution option to control type I error.
The genotypic data was subject to several quality control measures prior to whole-genome
linkage analysis. First, Pedcheck was used to exclude SNPs that were not consistent with
Mendelian segregation. Pedcheck is a program designed to check pedigree files to identify
genotype incompatibilities in linkage analysis (O’Connell and Weeks, 1998). Second, SNPs
that deviated from Hardy-Weinberg equilibrium (HWE) proportions (p<0.0001) were
identified using an algorithm that considers familial relationships (Bourgain et al., 2004) and
excluded from the analysis. Finally, the program Hclust was used to select a subset of SNPs
with low pairwise linkage disequilibrium (LD) to further reduce inflation of linkage
evidence. Hclust performs hierarchical cluster analysis to identify the most parsimonious set
of SNPs for further analysis based on linkage disequilibrium (Rinaldo et al., 2005)
All genotypes that passed the above quality checks, including those excluded by the Hclust
algorithm, were used to ascertain cryptic population substructure using the PCA (Principal
Components of Analysis) program from the Eigenstrat package. Eigenstrat was developed to
detect and correct for population stratification in genome-wide association studies (Price et
al., 2006). The computed values of the each component were grouped according to the
villages of residence. Although the first component had no obvious systematic structure, the
second component naturally split the genotyped sample into two groups, consistent with
proximity of the villages to the coast. This observation was used to define “community
group” as a dichotomous covariate included in subsequent analyses. The distribution of the
second principal component of ancestry is shown as a box plot in Figure 1. Communities 1,
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2, 3, 8, 9, and 11 (group 1) are located closer to the coast, while the remaining communities
(group 2) are considered upriver (tundra) communities.
Linkage analysis
SOLAR (Sequential Oligogenic Linkage Analysis Routines) was used to estimate the
heritability and to test for whole-genome linkage. SOLAR is an extensive software package
for genetic variance components analysis, including linkage (Almasy and Blangero, 1998).
The variance component approach implemented in SOLAR requires an estimate of locus
specific allelic sharing identical by descent (IBD), which was computed using MERLIN
(Multipoint Engine for Rapid Likelihood Inference). MERLIN uses the Lander-Green
approach to perform multipoint linkage analysis(Abecasis et al., 2002). All models run in
SOLAR included age, sex, community group, and n-3 PUFA intake. In order to allow for
non-linear effects of continuous covariates (age and n-3 PUFA intake) without undue
influence of extreme values, both of these covariates were included in the models as three
dichotomous variables to indicate quartiles.
Association analysis
All genotyped SNPs under linkage peaks identified in the linkage analysis that exceeded a
LOD score of 2 and satisfied HWE constraints were tested for association with the traits
using genetic association program ASSOC based on methods developed in George and
Elston (1987) and Elston et al. (1992), which models the full familial correlation structure of
the pedigree. ASSOC is a part of the Statistical Analysis for Genetic Epidemiology
(S.A.G.E) suite of software, and is used in pedigree studies to estimate associations between
traits and covariates as well as familial correlations, or heritability. The ASSOC program is
able to handle arbitrary pedigrees, so the original pedigree was used rather than the pedigree
processed by Pedstr (Kirichenko et al., 2009). All association models fit using ASSOC
included the same non-genetic covariates that were used for the linkage analysis: sex, age,
community group, and δ15N quartiles. For each SNP, three models were run: a baseline
model containing only non-genetic covariates; a model containing non-genetic covariates
and the SNP genotype as an additive effect; and a model containing non-genetic covariates,
SNP genotype as an additive effect, and interaction between SNP effect and δ15N quartiles.
Likelihood ratio tests were used to compare the models.
To correct for multiple testing in the association analyses, the effective number of SNPs was
determined using spectral decomposition of the correlation matrix (Li and Ji, 2005; Nyholt,
2004).
RESULTS
Clinical and demographic characteristics of the study population are presented by gender in
Table 3. Of 982 individuals in the study, approximately 3% (n=29) had diagnosed T2D.
Women represented slightly more than half of the overall study population, although that
proportion was higher (57%) in the upriver communities. Consistent with a recent report,
Yup’ik women had a higher intake of n-3 PUFAs as ascertained by δ15N (Nash et al., 2012),
as well as higher average fasting glucose, HbA1c and insulin relative to Yup’ik men. While
circulating triglycerides, LDL, and VLDL cholesterol did not vary by gender, Yup’ik
women had higher levels of total and HDL cholesterol as well as ApoA1, and Yup’ik men
had higher levels of ApoA2.
All linkage findings that exceeded the cutoff LOD score of 2 are presented as genome-wide
plots in Figure 2 and the corresponding linkage peaks are summarized in Table 4. In general,
our whole genome linkage analyses showed stronger evidence for genetic linkage with
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serum lipids relative to diabetes-related traits (FI, FG, or HbA1C). Specifically, we found a
region on chromosome 11 (11p13-11q13.1) with the most robust evidence for linkage with
LDL cholesterol (LOD score=3.02) that overlapped with the linkage peak for total
cholesterol (LOD score= 2.00). Additionally, we observed a region of interest on
chromosome 10 (10q23.1-10q24.1) which contained linkage peaks for HDL cholesterol
(LOD score= 2.72) and triglycerides (LOD= 2.21). We did not detect chromosomal regions
linked with ApoA1 or VLDL cholesterol.
Table 5 presents the results of genetic association testing for individual SNPs located in
regions identified by the genome-wide linkage scan. We identified four SNPs that were
nominally (P<0.05) associated with HDL cholesterol (P-values ranging from 0.0003 to
0.002), two that were associated with total cholesterol (P-values <0.006), and one associated
with ApoA2 (P=0.0009). However, the two markers on chromosome 11 that were significant
hits for total cholesterol were determined to be in perfect LD (r2=1) by the SNAP algorithm
(Broad Institute, Cambridge, MA). As shown in Table 5, we did not detect SNPs
associations with metabolic traits that were modified by n-3 PUFA intake.
DISCUSSION
In this study, we conducted a whole-genome linkage analysis in a Yup’ik population with a
historically low prevalence of T2D and identified chromosomal regions associated with
meatbolic traits. In addition to observing genetic linkage to several known loci associated
with plasma lipid/lipoprotein parameters on chromosome 19, these data demonstrate
preliminary evidence of novel candidate genetic determinants of several lipid traits. Of
particular biological interest is the high LD region on chromosome 11 containing
MACROD1 and NAA40, which was found to be associated with measurements of total
cholesterol in this sample of Yup’ik people.
MACROD1, also known as LRP16, is a gene with evidence of pleiotropic metabolic effects.
A recent large-scale meta-analysis of genome-wide association studies (Winkler et al., 2012)
has identified a locus in that gene as a sex-specific determinant of obesity-related traits like
the waist-to-hip ratio, showing a robust association in women but not men. Given that
women in Arctic communities have some of the highest visceral obesity rates in the world
(Risica et al., 2000; Voruganti et al., 2006), MACROD1/LRP16 variation in this population
may be an important contributor to health outcomes. Additionally, MACROD1/LRP16 has
been shown to activate nuclear factor κB (Wu et al., 2011), a key inflammatory component
of the pathogenesis of atherosclerosis (Kutuk and Basaga, 2003) that can be influenced by
environmental factors such as dietary cholesterol or statin therapy (Jasinska et al., 2007). It
is plausible that mutations in MACROD1/LRP1 that result in the decreased expression of
these genes have protective cardiometabolic effects in this population.
The quantitative trait loci (QTL) for HDL cholesterol on chromosome 19 are important for
the interpretation of the study results. First, they are confirmatory linkage results for this
study, as the identified genomic regions contain several loci—located in CILP2 for HDL
cholesterol and APOE/FLJ36070 for total cholesterol—that have been shown to be robustly
associated with lipid levels in a variety of populations (Teslovich et al., 2010; Yan et al.,
2011; Zhou et al., 2011). Additionally, they are consistent with data from another coastal
Alaska Native study population, the Genetics of Coronary Artery Disease in Alaska Natives
(GOCADAN) study (Cole et al., 2005), which identified a QTL for HDL levels (LOD=3.9)
and suggestive evidence for linkage of LDL size (LOD=2.5) and HDL size (LOD=2.3) to
the same genetic region. Cole et al. postulate that the LDL receptor gene (LDLR) represents
a strong positional candidate for this QTL, as it is located 1.5 Mbp from the peak evidence
of linkage. Second, the observed peaks are adjacent to the region containing QTL for several
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obesity-related anthropometric traits found the GOCADAN study (Voruganti et al., 2011).
This observation is consistent with another set of data from the GOCADAN population
(Voruganti et al., 2006) which suggests that cholesterol phenotypes and obesity-related
factors have shared genetic determinants in Alaska Native people. Future studies of putative
genetic associations with these phenotypes should account for such pleiotropic effects to
improve estimate validity and precision (Park et al., 2011).
Dietary n-3 PUFA intake did not modify the effect of genetic polymorphisms in the regions
of interest on phenotypes in this Yup’ik study population. Despite the biological plausibility
of such interactions, the null results of the interaction models do not support the role of long-
term PUFA in modifying the observed genotype-phenotype associations. However, a recent
study from the same population established that n-3 PUFAs may mediate the effect of
obesity-related SNPs on adiposity (Lemas et al., 2013).
These findings must be interpreted in light of several important considerations. First,
metabolic traits are complex and heterogeneous phenotypes that are likely to be influenced
by a combination of both rare and common genetic variants and multiple dietary and
lifestyle effects. While linkage analysis can efficiently detect families enriched with rare
biologically relevant polymorphisms, this method may not have sufficient power to detect
common variants of small or moderate effect size (Risch and Merikangas, 1996). To address
that limitation, we supplemented our whole genome linkage analysis by testing individual
SNPs within the linkage panel for association with lipid and diabetes-related traits. Notably,
several linkage peaks identified in our study were concordant with results from genome-
wide association studies in other populations (Teslovich et al., 2010). Second, the genetic
regions identified in this study represent preliminary evidence, which should be
independently replicated and followed with with functional genomic analyses in other
populations with low T2D prevalence. Finally, the specific SNPs that were found to be
significantly associated with metabolic traits may not represent the true susceptibility variant
but may be in LD with the functional polymorphism, precluding any causal interpretation of
these findings.
In conclusion, this study presents preliminary evidence of linkage between several genomic
regions and metabolic traits in a Yup’ik population with a historically low prevalence of
T2D. These results support the previous findings of lipid loci on chromosome 19 and
highlight the potential importance of MACROD1 to cardiometabolic health. Upon
successful validation, these findings may serve to elucidate the heritable determinants of
chronic disease in these genetically isolated, understudied communities and inform future
research and clinical efforts.
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Figure 1.
Distribution of second principal component of ancestry by village.
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Figure 2.
Genome-wide linkage scans for selected metabolic traits in Yup’ik people. The X-axis
shows the chromosomal location, and the Y-axis displays the LOD score.
A) Apolipoprotein A2
B) Fasting insulin
C) Glycosylated hemoglobin
D) High-density lipoprotein cholesterol
E) Total cholesterol
F) Triglycerides
G) Low-density lipoprotein cholesterol
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Table 1
Number of pairs of study participants by degree of relationship.
Degree of Relation Original Large Resulting Cut Remaining Small
Pedigree Pedigrees pedigrees
First 1149 1040 24
Second 1784 1011 13
Third 2363 777 2
Fourth 2489 399 2
Fifth 2236 121 1
Sixth 1533 31 -
Seventh 999 18 -
Eighth 447 4 -
Ninth 88 3 -
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Table 2
Heritability estimates of metabolic trait measurements.1
Residual Kurtosis h2 P
ApoA1 0.03 0.59 2×10−22
ApoA2 1.65 0.42 1×10−9
Fasting glucose 1.65 0.24 3×10−5
HbA1C 1.39 0.31 6×10−7
HDL cholesterol 0.13 0.44 7×10−14
Fasting insulin 2.49 0.15 0.006
LDL cholesterol 0.79 0.40 2×10−11
Total cholesterol 0.63 0.32 7×10−9
Triglycerides 0.10 0.45 3×10−13
VLDL cholesterol 0.08 0.43 9×10−13
1ApoA1, apolipoprotein A1; ApoA2, apolipoprotein A2; HbA1C, glycosylated hemoglobin; HDL, high density lipoprotein; LDL, low density
lipoprotein; VLDL, very low density lipoprotein
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Table 3
Descriptive characteristics of the study population (n=982).
Men (n=454)1 Women (n=528)1 P
Age, years 36 (35−38) 38 (37−40) 0.072
Community group, n
Coastal 214 (51) 204 (49) 0.633
Upriver 240 (43) 324 (57) 0.00043
δ15N, ‰ 8.8 (8.7-8.9) 9.2 (9.1-9.3) 0.00012
ApoA1, mg/dL 167 (117-217) 177 (128-225) <0.00012
ApoA2, mg/dL 27 (18-37) 26 (17-36) 0.0012
Fasting glucose, mg/dL 97 (75-118) 95 (74-115) 0.0062
HbA1C, mmol/mol 37.7 (29.9-44.8) 37.7 (28.5-46.1) 0.042
HDL cholesterol, mg/dL 54 (33-89) 62 (37-105) <0.00012
Fasting insulin, mU/L 16 (4-28) 19 (5-34) <0.00012
LDL cholesterol, mg/dL 137 (58-216) 136 (63-209) 0.772
Total cholesterol, mg/dL 210 (115-304) 217 (129-306) 0.012
Triglycerides, mg/dL 121 (35-207) 115 (38-192) 0.432
VLDL cholesterol, mg/dL 24 (7-42) 23 (8-39) 0.572
Body mass index, kg/m2 26 (18-36) 28 (18-44) <0.00012
Body fat, % 21 (6-36) 35 (18-53) <0.00013
Abdominal skinfold thickness, mm 15 (4-62) 29 (12-72) <0.00012
1
Mean (95% confidence interval) for continuous variables or n (% total) for categorical variables
2P calculations are based on the 2-sample t-test, not accounting for the family structure.
3P calculations are based on the binomial distribution, not accounting for the family structure.
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Table 4
Linkage peaks exceeding LOD score of 2.
Peak
Chromosome Start End
LOD Start SNP End SNP
Bands Position1 Position1
Score
ApoA2
2p11.2-2q14.2 2.46 rs1015117 86,594,374 rs280192 121,453,668
4q28.3-4q31.21 2.09 rs1992695 138,031,197 rs336332 143,249,272
4q35.1-4q35.2 2.23 rs1158465 186,706,487 rs1915852 191,026,530
21q22.3 2.42 rs4920106 42,748,803 rs2256207 46,886,508
Fasting Insulin
8q22.3-8q23.3 2.12 rs718262 103,045,180 rs1353277 116,148,616
HbA1C
11p15.4-11p15.1 2.28 rs1425151 10,644,793 rs214101 17,245,930
HDL cholesterol
1q31.3-1q32.1 2.12 rs1538686 194,664,442 rs4351714 201,027,281
3p22.3-3p22.1 2.42 rs4796 32,498,781 rs1996562 40,110,750
8p21.2-8p12 2.65 rs310319 23,746,576 rs8685 33,477,812
10q23.1-10q23.2 2.72 rs720262 82,462,543 rs10887683 88,706,557
13q12.13-13q12.3 2.06 rs306395 25,348,564 rs717651 30,070,594
19p13.11-19q12 2.37 rs7250192 18,584,325 rs2194198 36,728,531
LDL cholesterol
2q34-2q36.1 2.12 rs1396828 210,753,727 rs1463991 221,411,990
11p13-11q13.1 3.02 rs2045040 34,575,332 rs633727 64,416,000
Total cholesterol
2q35-2q36.1 2.27 rs207928 216,744,686 rs348971 222,626,435
4q28.3-4q31.1 2.00 rs13103412 136,871,469 rs6840033 141,448,311
11q12.2-11q13.2 2.00 rs1530354 59,957,022 rs1695 67,109,265
Triglycerides
10q23.1-10q23.33 2.21 rs489466 84,638,946 rs2298037 96,736,068
1
Position was determined using hg18 as the reference genome.
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Table 5
Significant associations between single nucleotide polymorphisms within linkage peaks and metabolic traits in
the study population.
Trait SNP Chromosome Gene P (Add)1 P (Full)2 P(Int) 3
ApoA2
rs1317423 4 -- 0.0009 0.009 0.48
HDL
rs713144 3 -- 0.002 0.01 0.38
rs2475793 10 NRG3 0.0003 0.006 0.63
rs535534 13 POLR1D 0.001 0.005 0.24
rs2194198 19 -- 0.0009 0.001 0.50
Total cholesterol
rs728919 11 NAA40 0.003 0.06 0.97
rs562865 11 MACROD1 0.003 0.06 0.94
1
Model included sex, age, n-3 PUFA intake, community group, and additive genetic term.
2
Model included all terms listed above plus an interaction between the additive genotype and n-3 PUFA intake.
3P-value from the likelihood ratio test for interaction between the additive genotype and n-3 PUFA intake.
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